ES2119682B1 - Una composicion farmaceutica que contiene delapril y manidipino para el tratamiento de enfermedades cardiovasculares y renales. - Google Patents

Una composicion farmaceutica que contiene delapril y manidipino para el tratamiento de enfermedades cardiovasculares y renales.

Info

Publication number
ES2119682B1
ES2119682B1 ES09601015A ES9601015A ES2119682B1 ES 2119682 B1 ES2119682 B1 ES 2119682B1 ES 09601015 A ES09601015 A ES 09601015A ES 9601015 A ES9601015 A ES 9601015A ES 2119682 B1 ES2119682 B1 ES 2119682B1
Authority
ES
Spain
Prior art keywords
manidipine
cardiovascular
kidney diseases
delapril
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
ES09601015A
Other languages
English (en)
Spanish (es)
Other versions
ES2119682A1 (es
Inventor
Yoshiyuki Inada
Paolo Chiesi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chiesi Farmaceutici SpA
Takeda Pharmaceutical Co Ltd
Original Assignee
Chiesi Farmaceutici SpA
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici SpA, Takeda Chemical Industries Ltd filed Critical Chiesi Farmaceutici SpA
Publication of ES2119682A1 publication Critical patent/ES2119682A1/es
Application granted granted Critical
Publication of ES2119682B1 publication Critical patent/ES2119682B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
ES09601015A 1995-05-09 1996-05-07 Una composicion farmaceutica que contiene delapril y manidipino para el tratamiento de enfermedades cardiovasculares y renales. Expired - Fee Related ES2119682B1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95830186 1995-05-09

Publications (2)

Publication Number Publication Date
ES2119682A1 ES2119682A1 (es) 1998-10-01
ES2119682B1 true ES2119682B1 (es) 1999-07-01

Family

ID=8221919

Family Applications (1)

Application Number Title Priority Date Filing Date
ES09601015A Expired - Fee Related ES2119682B1 (es) 1995-05-09 1996-05-07 Una composicion farmaceutica que contiene delapril y manidipino para el tratamiento de enfermedades cardiovasculares y renales.

Country Status (4)

Country Link
BR (1) BR1101039A (pt)
ES (1) ES2119682B1 (pt)
FR (1) FR2733911B1 (pt)
IT (1) IT1285093B1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE220333T1 (de) 1996-04-05 2002-07-15 Takeda Chemical Industries Ltd Pharmazeutische kombination enthaltend einen wirkstoff mit angiotensin-ii antagonistischer aktivität und einen wirkstoff der die insulin- sensitivität erhöht
IT1398168B1 (it) * 2010-02-16 2013-02-14 Chiesi Farma Spa Uso di ingredienti attivi in combinazione per il trattamento delle complicanze del diabete.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU569789B2 (en) * 1984-05-03 1988-02-18 Brigham And Women's Hospital A.c.e. inhibitors to treat renal diseases
EP0259838A3 (en) * 1986-09-09 1989-11-15 Syntex (U.S.A.) Inc. Pharmaceutical composition containing a 1,4-dihydropyridine derivative and an acylated 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid
DE3633496A1 (de) * 1986-10-02 1988-04-14 Hoechst Ag Kombination von angiotensin-converting-enzyme-hemmern mit calciumantagonisten sowie deren verwendung in arzneimitteln
NL8702502A (nl) * 1986-11-03 1988-06-01 Sandoz Ag Farmaceutisch preparaat voor toepassing tegen hypertensie en congestieve cardiale insufficientie.
TW197945B (pt) * 1990-11-27 1993-01-11 Hoechst Ag
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
JPH06172220A (ja) * 1992-12-03 1994-06-21 Upjohn Co:The 虚血性疾患治療用医薬組成物
DE4308504A1 (de) * 1993-03-18 1994-09-22 Knoll Ag Neue Verwendung einer Kombination aus Verapamil und Trandolapril

Also Published As

Publication number Publication date
BR1101039A (pt) 2002-04-02
IT1285093B1 (it) 1998-06-03
FR2733911A1 (fr) 1996-11-15
ITTO960379A0 (it) 1996-05-08
FR2733911B1 (fr) 1998-05-29
ES2119682A1 (es) 1998-10-01
ITTO960379A1 (it) 1997-11-08

Similar Documents

Publication Publication Date Title
UY25242A1 (es) Inhibidores de benzotiazol de la proteína tirosina cinasa
ES2185817T3 (es) Formas de dosificacion farmaceutica oral que comprenden un inhibidor de las bombas de protones y un agente antiacido o alginato.
ES2185816T3 (es) Formas de dosificacion farmaceutica para la via oral, que comprenden un agente inhibidor de la bomba de protones y un agente procinetico.
AR005282A1 (es) Composición farmacéutica oral en la forma de un comprimido de unidades múltiples, uso de la misma para la preparación de medicamnetos, y procedimiento para su manufactura.
AR047841A1 (es) Metodos y composiciones para el tratamiento de transtornos inmunoinflamatorios
BR0008958A (pt) Inibidores de reabsorção de monoamina para otratamento de distúrbios do snc
TR199901417T2 (xx) Analjezik etkisi olan yeni bile�imler.
ES2188177T3 (es) Composicion para la prevencion y/o el tratamiento de la osteoporosis y las alteraciones debidas al sindrome menopausico, que comprende propionil-l-carnitina y genisteina.
AR007609A1 (es) Una composicion farmaceutica
UY24354A1 (es) Composiciones farmacéuticas que contienen epinastina
BRPI0414876A (pt) compostos e composições farmcêuticas para prevenção de overdose ou abuso e respectivos usos
ECSP055738A (es) PROCESO ENANTIOSELECTIVO PARA LA PREPARACIÓN DE AMBOS ENANTIÓMEROS DE 10,11-DIHIDRO-10-HIDROXI-5H-DIBENZ-[b,f]-AZEPIN-5-CARBOXAMIDA Y SUS NUEVAS FORMAS DE CRISTAL
CO4340681A1 (es) Procedimientos de uso para la inhibicion de la perdida osea y la disminucion del colesterol en suero
DK0662958T3 (da) 1-(2-Oxoacetyl)piperidin-2-carboxylsyrederivater som multilægemiddelresistente cancercellesensibiliserende midler
ES2060825T3 (es) Un sistema terapeutico para el administracion retardada y controlada de sustancias activas por via percutanea o a traves de la mucosa.
AR042051A1 (es) Tratamiento combinado contra el cancer con un compuesto anti-cancerigeno activado por glutationa s- transferasa (gst) y otro tratamiento contra el cancer
DK1370260T3 (da) Azoler, som malonyl-coa-decarboxylaseinhibitorer anvendelige som mataboliske modulatorer
AR033325A1 (es) Composicion que comprende una carnitina y glutationa , util para incrementar la absorcion de la glutationa y sinergizar sus efectos, un complemento dietario, medicamento, la utilizacion de una composicion de combinacion para preparar un complemento dietario o un medicamento
CO5700723A2 (es) Uso de un derivado de amina ciclica especifico o de sus sales farmaceuticamente aceptables para tratar y prevenir la insuficiencia cardiaca
AR034813A1 (es) Composiciones farmaceuticas y uso de las mismas
AR026254A1 (es) El uso de una preparacion de liberacion controlada para la preparacion de un medicamento para aumentar la dosis o la exposicion sistemica de un farmaco queinhibe la fosfodiesterasa 4
DE502004010514D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von Rhinitiden
ES2180729T3 (es) Tratamiento terapeutico combinado de las patologias hiperproliferantes.
DK0634396T3 (da) Aminosyrederivater og deres anvendelse som enkeltfalinaseinhibitorer
AR036321A1 (es) Metodo y formulacion farmaceutica para el tratamiento de la discinesia de aparicion tardia.

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19981001

Kind code of ref document: A1

Effective date: 19981001

PC2A Transfer of patent
FD2A Announcement of lapse in spain

Effective date: 20160826